Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 6/20 | 0.57 |
| ▸ | GRIN2A | Q12879 | 6/20 | 0.57 |
| ▸ | GRIN2D | O15399 | 5/20 | 0.57 |
| ▸ | GRIN3B | O60391 | 5/20 | 0.57 |
| ▸ | GRIN2B | Q13224 | 5/20 | 0.57 |
| ▸ | GRIN2C | Q14957 | 5/20 | 0.57 |
| ▸ | GRIN3A | Q8TCU5 | 5/20 | 0.57 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | SLC22A1 | O15245 | 2/20 | 0.38 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.38 |
| ▸ | MTOR | P42345 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22193933 | 0.87 | MEN1 (0.39) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL11667978 | 0.76 | MEN1 (0.33) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL11668112 | 0.76 | MEN1 (0.33) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL11668171 | 0.74 | ALDH1A1 (0.49) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL292823 | 0.72 | GRIN1 (1.00) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL1931239 | 0.72 | MEN1 (0.55) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL820843 | 0.72 | MEN1 (0.34) | MEN1ALDH1A1KMT2A | |
| SCHEMBL22193935 | 0.69 | — | — | |
| SCHEMBL25799584 | 0.69 | GRIN1 (0.70) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL821936 | 0.69 | GRIN2D (0.46) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110282100-A1 | PROCESS FOR PREPARING MEMANTINE | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-11-17 | — | — | US | disclosed |
| US-20080275112-A1 | Invention Concerning Aminoadamantane Compounds | SCHREINER PETER R | 2008-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282100-A1 | PROCESS FOR PREPARING MEMANTINE | PSEN2, SLC6A2, PNMT | GRIN1 46/4885GRIN2A 7/4885GRIN2D 59/4885 |
| US-20080275112-A1 | Invention Concerning Aminoadamantane Compounds | GABRA5, GABRA1, GABRA4 | GRIN1 44/4885GRIN2A 77/4885GRIN2D 117/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.